SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
about
Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsProteomics in epigenetics: new perspectives for cancer researchQuantification of histone modifications using ¹⁵N metabolic labelingQuantitative proteomic analysis of histone modificationsDiscovery of histone modification crosstalk networks by stable isotope labeling of amino acids in cell culture mass spectrometry (SILAC MS)PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples.The ChroP approach combines ChIP and mass spectrometry to dissect locus-specific proteomic landscapes of chromatin.Histone H4 acetylation differentially modulates arginine methylation by an in Cis mechanism.Quantitative proteomic approaches to studying histone modifications.Development of new multifunctional terpolymer sorbent for proteomics applications.Breaking the histone code with quantitative mass spectrometry.Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples.Development of a test to identify bladder cancer in the urine of patients using mass spectroscopy and subcellular localization of the detected proteins.Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach.Identification and interrogation of combinatorial histone modifications.Quantitative proteomics using SILAC: Principles, applications, and developments.The contribution of mass spectrometry-based proteomics to understanding epigenetics.Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach.Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics.Improved bottom-up strategy to efficiently separate hypermodified histone peptides through ultra-HPLC separation on a bench top Orbitrap instrument.Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27.Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.Mass spectrometry-based proteomics for the analysis of chromatin structure and dynamics.Chromatin proteomics reveals novel combinatorial histone modification signatures that mark distinct subpopulations of macrophage enhancers.Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome.Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases.SILAC-Based Quantitative Strategies for Accurate Histone Posttranslational Modification Profiling Across Multiple Biological Samples.Extensive and systematic rewiring of histone post-translational modifications in cancer model systems.SILAC-based quantitative MS approach for real-time recording protein-mediated cell-cell interactions.Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation
P2860
Q26781745-10470A01-0D7C-417C-A354-FA814BB9F3E1Q27014943-FAB1EF76-8A90-40FD-8AB8-76168D89B747Q27027990-CB2E9E10-61BD-456B-95A5-307446D9E57DQ30375585-236A7EDF-5AF4-459B-8A54-A33AB7010DD7Q30411607-570C7056-12D5-4D50-9BB6-222AF722A8D8Q33892492-17F667DD-6EE6-46A6-870F-ABED7E39FFE9Q34201535-A29426C6-4318-41BA-886F-8E18A987FDA9Q35063526-07F42ACD-2EE7-48FF-83C1-1C9381CF83F2Q35228865-B3041CD0-9B48-4E12-85AE-E68389537CEBQ35426621-761D27E4-00C0-4875-9C3C-D22D305EFAEEQ35645008-18B00BCC-3456-4AED-BE27-CE068834A124Q35805423-3CE4F2E4-6CA7-4733-BBA6-2B02D263F29EQ36057205-2E9C9EB7-A8D9-48D9-90CE-B26EFB86B4D1Q37054065-65E9FFC5-EE8D-47B2-A7E9-A646E0C441A6Q38175981-5E631767-B055-458A-9361-EE0CCE55FC2AQ38533946-952D968B-1D67-4A87-9761-3873E7171687Q38647501-9E4FFE03-05C1-4723-BD12-97989C3DC659Q38715343-D2E5C7D0-D2B9-4CC9-B7EA-7EBA0D9DF899Q38805063-174EE56A-5A46-416D-9DE7-046C61A33776Q38970523-D6327B1D-7E6D-4F67-91B3-B88462D46BD6Q39026274-9DAA6F03-E5A1-4F39-A9A5-61EB6227F033Q39468169-4A395E23-01A0-431A-B206-7F3F320A1583Q40042389-6E09E1A4-8204-4456-8F2F-8F2D98945444Q42778020-18FEB8A6-00DF-4C8D-9441-DE1F20821C3EQ44209738-14B73248-2308-4A9B-A0AF-9145A886162CQ48276563-7D601534-7A8A-4238-89BB-135635DE8306Q48932155-93B77633-FA26-4194-9AB1-47D3F34F19D8Q52332024-D08260DD-D316-4BEB-A43B-782EEAF89042Q55075973-0F8E9385-027F-46A5-8F85-9B9342A24FCCQ57474446-EB2743AD-47C3-4E9A-9AE5-442BF67408E1
P2860
SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
SILAC-based proteomic analysis ...... of human breast cancer cells.
@en
SILAC-based proteomic analysis ...... of human breast cancer cells.
@nl
type
label
SILAC-based proteomic analysis ...... of human breast cancer cells.
@en
SILAC-based proteomic analysis ...... of human breast cancer cells.
@nl
prefLabel
SILAC-based proteomic analysis ...... of human breast cancer cells.
@en
SILAC-based proteomic analysis ...... of human breast cancer cells.
@nl
P2093
P2860
P1433
P1476
SILAC-based proteomic analysis ...... of human breast cancer cells.
@en
P2093
Alessandro Cuomo
Saverio Minucci
Simona Moretti
P2860
P2888
P304
P356
10.1007/S00726-010-0668-2
P577
2010-07-09T00:00:00Z